miR-193a-3p Regulates the Multi-Drug Resistance of Bladder Cancer by Targeting the LOXL4 Gene and the Oxidative Stress Pathway

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR‑144‑3p Regulates the Resistance of Lung Cancer to Cisplatin by Targeting Nrf2

Oncology Reports
MedicineCancer ResearchOncology
2018English

MiR-20a-5p Represses the Multi-Drug Resistance of Osteosarcoma by Targeting the SDC2 Gene

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

miR-17-3P Regulates the Proliferation and Survival of Colon Cancer Cells by Targeting Par4

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

NT21MP Negatively Regulates Paclitaxel-Resistant Cells by Targeting miR‑155‑3p and miR‑155-5p via the CXCR4 Pathway in Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

Downregulation of miR-193a-3p Is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2020English

GENE MIR-193A-3P Influence Osteoblast Differentiation Through Up-Regulation of LGR4/ATF4 Signaling Pathway

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

miR-200a-3p Predicts Prognosis and Inhibits Bladder Cancer Cell Proliferation by Targeting STAT4

Archives of Medical Science
Medicine
2019English

MiR-126 Regulates Proliferation and Invasion in the Bladder Cancer BLS Cell Line by Targeting the PIK3R2-mediated PI3K/Akt Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2016English

LINC00528 Regulates Myocardial Infarction by Targeting the miR-143-3p/COX-2 Axis

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy